PORTLAND, OR (July 13, 2017) – Janrain®, the company that pioneered the Customer Identity and Access Management (CIAM) category, today announced its membership in Align Biopharma™, an industry technology standards group that includes 23 leading biopharma companies and technology and service providers. The group is creating and implementing open technology standards that make it easier for healthcare professionals (HCPs) to connect digitally with life sciences companies. Janrain, among the tech leaders joining Align Biopharma today, provides customer-driven identity management platform for global pharma companies, such as Pfizer and Merck. Janrain is the only identity management provider to be HIPAA/HITECH-certified.
Each new drug introduced to the market comes with a great deal of tailored information required by doctors. HCPs have had difficulty accessing and establishing the true source of this information due to the complexity of navigating the multitude of digital content and channels. In response to this, Align Biopharma has defined an identification and authentication standard that enables single sign-on for HCPs to access online content—including websites, portals, virtual events or webinars—directly from the life sciences companies. Align Biopharma is also defining the standards for consent and preference management so that there is consistency in how HCPs specify communication preferences with each company—an essential component for companies that do business in the EU and must comply with the General Data Protection Regulation (GDPR) scheduled to go into effect in May of 2018.
“Janrain began investing in the pharma category in 2010 and now serves a majority of the top 10 pharmaceutical companies globally,” said Jim Kaskade, CEO of Janrain. “Our excitement around Align Biopharma is first rooted in our passion to innovate in digital identity, but then also in our passion to collaborate and share those innovations with the identity industry. Janrain’s commitment to open standards began when we helped form the OpenID foundation. We’re very eager to contribute our pharma learnings from over the past seven years and to help advance not only the HCP’s experiences, but patients’ experiences and our client organizations’ experiences.”
“The industry’s response to Align Biopharma has been extremely positive,” said Henry Levy, president of Align Biopharma. “Members such as Janrain will help healthcare professionals get the timely information they need, so that they can focus on the important task of treating patients.”
To learn more about the leading companies working to create and implement open technology standards, read today’s press release from Align Biopharma.
Align Biopharma is an industry standards group made up of more than 20 leading pharmaceutical companies and technology and service providers that are dedicated to making it faster and easier for healthcare professionals to connect with the life sciences industry. For more information, visit AlignBiopharma.org.